Evidence map›Paper›PMID 40737173›Full record

ArticleJournal of medical microbiology2025

Dissecting rifampicin heteroresistance in

Katherine Vallejos-Sanchez, Diego A Taquiri-Díaz, Omar A Romero-Rodriguez, A Paula Vargas-Ruiz, Jorge Coronel, Arturo Torres, Jose L Perez-Martinez, Adiana Ochoa-Ortiz, Robert H Gilman, Louis Grandjean and 3 more

Abstract read
In one paragraph

Article in Journal of medical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Open-access genomic drug resistance prediction tools forJournal of clinical microbiology · 2026
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Katherine Vallejos-SanchezLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.
Diego A Taquiri-DíazLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.
Omar A Romero-RodriguezLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.
A Paula Vargas-RuizLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.
Jorge CoronelLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.
Arturo TorresDepartment of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London WC1N 1EH, UK.
Jose L Perez-MartinezLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.
Adiana Ochoa-OrtizLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.
Robert H GilmanInternational Health Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Louis GrandjeanDepartment of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London WC1N 1EH, UK.
Martin Cohen-GonsaudCentre de Biologie Structurale, CNRS, INSERM, Montpellier 34090 , France.
Mirko ZimicLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.
Patricia SheenLaboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, San Martín de Porres 15102, Lima, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsDrug Resistance, BacterialMycobacterium tuberculosisRifampinBacterial ProteinsGenome, BacterialGenotypeHumansMicrobial Sensitivity TestsPeruPhenotypePilot ProjectsRetrospective StudiesTuberculosisTuberculosis, Multidrug-ResistantWhole Genome SequencingAntitubercular AgentsBacterial ProteinsRifampinheteroresistancemixed populationsrifampicintuberculosiswhole-genome sequencing (WGS)

Identifiers

PMID40737173
PMCPMC12310241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.